Answers are grounded in this paper and cite their sources.
Single-cell RNA sequencing reveals tumor microenvironment differences in HPV-positive and HPV-negative penile squamous cell carcinoma, suggesting implications for treatment.
Background Penile squamous cell carcinoma (PSCC) is a rare yet potentially lethal malignancy, often resulting in devastating disfigurement, with a 5-year survival rate of only ∼50%. Human papillomavirus (HPV) infection is implicated in approximately half of PSCC cases and is associated with improved clinical outcomes; however, the underlying mechanisms remain poorly understood. Methods To elucidate HPV-associated differences in the tumor microenvironment (TME), we performed single-cell RNA sequencing (scRNA-seq) on tumors from 11 treatment-naïve PSCC patients, analyzing a total of 52 980 single cells. Unsupervised clustering identified 49 distinct cellular clusters across immune and stromal compartments. Results HPV-positive tumors exhibited an increased abundance of mast cells and a reduction of proliferative macrophages subpopulation compared to HPV-negative tumors. Notably, CD8+ T cells in HPV-positive PSCC expressed lower levels of immune checkpoint molecules, suggesting a less exhausted immune state. Conversely, TIGIT and its ligands were significantly enriched in HPV-negative tumors, potentially fostering an immunosuppressive niche. Conclusion Collectively, our study delineates the single-cell landscape of PSCC and highlights distinct TME remodeling associated with HPV status, suggesting that the reduced immunosuppression in HPV-positive tumors may underlie their more favorable prognosis.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: